中华外科杂志
中華外科雜誌
중화외과잡지
CHINESE JOURNAL OF SURGERY
2009年
2期
109-111
,共3页
薛文%管晓鹂%刘林%刘杰%王和平
薛文%管曉鸝%劉林%劉傑%王和平
설문%관효리%류림%류걸%왕화평
脊柱%骨髓炎%化脓%成年人
脊柱%骨髓炎%化膿%成年人
척주%골수염%화농%성년인
Spine%Osteomyelitis%Suppuration%Adult
目的 总结23例成人血源性脊柱化脓性骨髓炎(PDVO)的临床诊治经验.方法 对1999年7月至2006年10月收治的23例成人血源性PDVO患者的病史、临床表现、诊断、治疗及转归等进行回顾性分析.结果 本组23例,男15例,女8例;平均年龄55.4岁.诊治延误时间4周~11个月,平均4.4个月.其中患有或合并患有下述1种以上疾病的17例:糖尿病、泌尿系感染、酒精中毒、肝硬化、风湿性关节炎以及长期滥用糖皮质激素.全部23例实验室检查C反应蛋白和红细胞沉降率均有升高,而白细胞计数仅有9例升高.7例保守治疗;16例前路病灶清创植骨融合,其中11例脊柱不稳的选择适当的内固定,3例采用一期椎体侧前方钢板固定.7例采用二期后路融合椎弓根螺钉固定.本组23例全部获随访,随访时间6个月~7年,平均27个月.患者生活均能自理,无复发.手术治疗的患者,术后症状迅速缓解,植骨融合率达87.5%.结论 成人血源性PDVO好发于患有内科疾病的老年患者,血培养阳性有助于确诊.对于保守治疗失败的慢性PDVO的患者,手术清创植骨融合配合适当的内固定,能迅速缓解症状,安全有效.
目的 總結23例成人血源性脊柱化膿性骨髓炎(PDVO)的臨床診治經驗.方法 對1999年7月至2006年10月收治的23例成人血源性PDVO患者的病史、臨床錶現、診斷、治療及轉歸等進行迴顧性分析.結果 本組23例,男15例,女8例;平均年齡55.4歲.診治延誤時間4週~11箇月,平均4.4箇月.其中患有或閤併患有下述1種以上疾病的17例:糖尿病、泌尿繫感染、酒精中毒、肝硬化、風濕性關節炎以及長期濫用糖皮質激素.全部23例實驗室檢查C反應蛋白和紅細胞沉降率均有升高,而白細胞計數僅有9例升高.7例保守治療;16例前路病竈清創植骨融閤,其中11例脊柱不穩的選擇適噹的內固定,3例採用一期椎體側前方鋼闆固定.7例採用二期後路融閤椎弓根螺釘固定.本組23例全部穫隨訪,隨訪時間6箇月~7年,平均27箇月.患者生活均能自理,無複髮.手術治療的患者,術後癥狀迅速緩解,植骨融閤率達87.5%.結論 成人血源性PDVO好髮于患有內科疾病的老年患者,血培養暘性有助于確診.對于保守治療失敗的慢性PDVO的患者,手術清創植骨融閤配閤適噹的內固定,能迅速緩解癥狀,安全有效.
목적 총결23례성인혈원성척주화농성골수염(PDVO)적림상진치경험.방법 대1999년7월지2006년10월수치적23례성인혈원성PDVO환자적병사、림상표현、진단、치료급전귀등진행회고성분석.결과 본조23례,남15례,녀8례;평균년령55.4세.진치연오시간4주~11개월,평균4.4개월.기중환유혹합병환유하술1충이상질병적17례:당뇨병、비뇨계감염、주정중독、간경화、풍습성관절염이급장기람용당피질격소.전부23례실험실검사C반응단백화홍세포침강솔균유승고,이백세포계수부유9례승고.7례보수치료;16례전로병조청창식골융합,기중11례척주불은적선택괄당적내고정,3례채용일기추체측전방강판고정.7례채용이기후로융합추궁근라정고정.본조23례전부획수방,수방시간6개월~7년,평균27개월.환자생활균능자리,무복발.수술치료적환자,술후증상신속완해,식골융합솔체87.5%.결론 성인혈원성PDVO호발우환유내과질병적노년환자,혈배양양성유조우학진.대우보수치료실패적만성PDVO적환자,수술청창식골융합배합괄당적내고정,능신속완해증상,안전유효.
Objective In order to sum up the experience of diagnosis and treatment, the clinical information, diagnostic approach and treatment strategies from 23 patients with hematogenous pyogenic discitis and vertebral osteomyelitis (PDVO) in adults were reviewed. Methods A retrospective record review was conducted of all cases of hematogenous PDVO from July 1999 to October 2006, the diagnostic approach and the treatment strategies were discussed. Results The average age was 55.4 years. The average delayed diagnosis time was 4.4 months ( range, 4 weeks to 11 months). Of these, 17 had underlying diseases such as diabetes mellitus, chronic alcoholism, liver cirrhosis, rheumatic disease, and the use of corticosteroids. All percent had elevated erythrocyte sedimentation rates and C-reactive proteins, while white blood cell counts were less reliably elevated. Imaging studies included radiographs and MRI. Seven patients were treated with immobilization and intravenous antibiotic drugs. Because of a delay in diagnosis, 16 patients underwent operative treatment for hematogenous PDVO using staged anterior debridement and Bone grafting with iliac crest or rib strut, anterior spinal instrumentation in 3 patients, posterior instrumentation was placed in 7 patients at a second procedure 10 days to 2 weeks following initial operation. Twenty-three patients were followed-up for an average period of 27 months, with a minimum of 6 months and the longest for7 years. The patients return to their preoperative everyday activity. No patient had a recurrence of osteomyelitis. All their symptoms improved after surgery, bony fusion occurred in 87.5% of cases. Conclusions Adult hematogenous PDVO is a disease that affects mainly older patients suffering underlying medical illnesses. Positive blood cultures is valuable for the diagnosis. Hematogenous PDVO may require surgery in case of a development of biomechanical instability and/or a vertebral collapse with progressive deformity. In experienced hands, surgical debridement, interbody fusion, and anterior or posterior iustrumentation is a safe and effective treatment.